AQP4 and neuromyelitis optica: A pathogenic role of anti-AQP4 antibodies in the development of NMO has been demonstrated both in vitro, by the fact that caused complement-mediated astrocyte cytotoxicity [4–6], and in vivo, by passive transfer experiments in animal models [7–9].